Sort
10,766 grants matching “checkpoint inhibitor”
LKB1/AMPK Signaling and Peutz-Jeghers Syndrome
$457,700Lewis C Cantley · Brigham And Women'S Hospital · P01 · FY2008 · CA
Modulating Intratumoral Immune Composition to Enhance Immunotherapy
$457,683Edwin Manuel · Beckman Research Institute/City Of Hope · R21 · FY2024 · CA
An Environmental Chemical Receptor, the AhR, as a Mediator of Multiple Immune Checkpoints in Oral Cancer
$457,675David H Sherr · Boston University Medical Campus · R01 · FY2024 · ES
LILRB modulates tumor microenvironment and promotes tumor progression
$457,636Shu-Hsia Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
Breaking down tumor immune privilege through targeted hypoxia reduction
$457,607Michael A. Curran · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Role of T Regulatory Cells in Chronic Infection
$457,509Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Mechanisms of Tumor Derived Neutrophil Induced Apoptosis in Lymphocytes
$457,095A. McGarry Houghton · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Decoding tobacco-related oral cancer ecosystem by integrative approach
$457,093Aik Choon Tan · University Of Utah · R01 · FY2023 · DE
Novel multipronged Immunovirotherapy Approach for GBM Treatment
$456,968Evanthia Galanis · Mayo Clinic Rochester · R01 · FY2023 · CA
Targeting Lysosomal Vulnerabilities in Renal Pathogenesis
$456,791Steffan T Nawrocki · University Of Arizona · R01 · FY2024 · CA
Project 1: Promoting Graft-versus-Tumor Effects in the Bone Marrow
$456,745Geoffrey Roger Hill · Fred Hutchinson Cancer Center · P01 · FY2025 · CA
The Role of Akt in Cell Survival and Cell Growth
$456,744Nissim Hay · University Of Illinois At Chicago · R01 · FY2022 · AG
The Role of Akt in Cell Survival and Cell Growth
$456,744Nissim Hay · University Of Illinois At Chicago · R01 · FY2023 · AG
The Role of Akt in Cell Survival and Cell Growth
$456,744Nissim Hay · University Of Illinois At Chicago · R01 · FY2020 · AG
The Role of Akt in Cell Survival and Cell Growth
$456,744Nissim Hay · University Of Illinois At Chicago · R01 · FY2021 · AG
Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment
$456,744Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Cell-Selective CpG-STAT3 Inhibitors for Radioimmunotherapy of Malignant Glioma
$456,635Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Project 1: Decoding, Modeling and Targeting Oncohistones and an Oncohistone-like Protein
$456,487Nada Jabado · Rockefeller University · P01 · FY2020 · CA
Tumor cell -TAM Paracrine Signaling in Breast Cancer
$456,441Elizabeth S. Yeh · Indiana University Indianapolis · R01 · FY2023 · CA
Bone marrow-derived myeloid cell dysregulation in malignant progression of glioma
$456,284Prajwal Rajappa · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · NS
Defining the role of macropinocytosis in solid tumor growth and therapeutic resistance
$456,227Aimee L Edinger · University Of California-Irvine · R01 · FY2024 · CA
Targeting the LIFR-LCN2 pathway to improve liver cancer therapy
$456,124Li Ma · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Central mechanisms of glucocorticoid circadian rhythm dysfunction in breast cancer
$456,048Jeremy Borniger · Cold Spring Harbor Laboratory · R01 · FY2024 · CA
Regulation of the cell cycle by SCF and APC/C ubiquitin ligases
$456,031Michele Pagano · New York University School Of Medicine · R01 · FY2012 · GM
Regulation of the cell cycle by SCF and APC/C ubiquitin ligases
$456,031Michele Pagano · New York University School Of Medicine · R01 · FY2014 · GM